Zydus Cadila announced the Day 1 launch of Ramelteon Tablets (US RLD Rozerem Tablets), 8 mg upon receiving the final approval from the USFDA. Ramelteon is a sedative, also called a hypnotic.
It works by affecting certain substances in the body that help regulate the "sleep-wake cycle." Ramelteon is used to treat insomnia that is associated with having trouble falling asleep. The drug will be manufactured at the group's formulations manufacturing facility at SEZ, Ahmedabad.
Powered by Capital Market - Live News
(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)